See ENTYVIO treatment options, infusion and subcutaneous injection, for Crohn's disease and ulcerative colitis. See Safety and Prescribing Information.

Apr 18, 2024 · ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active …

ENTYVIO® dosing and administration for IV infusion and subcutaneous injection. Find infusion schedule, storage, and injection site information.

Nov 28, 2025 · Entyvio is used to treat moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD) in adults. Entyvio infusion is administered intravenously for the first two …

Nov 19, 2025 · Yes, ENTYVIO (vedolizumab) is available as an injection for maintenance therapy in adults with moderately to severely active Crohn's disease and ulcerative colitis. This self …

Entyvio, also known by its generic name Vedolizumab, is a medical drug used to treat moderate to severe ulcerative colitis and Crohn’s disease in patients who don’t show improvement while on …

Vedolizumab, sold under the brand name Entyvio, is a monoclonal antibody medication developed by Takeda Oncology for the treatment of ulcerative colitis and Crohn's disease. [5]

MEDICAL INFORMATION Entyvio Key Facts What is Entyvio? Entyvio is the brand name for vedolizumab and is available as a subcutaneous injection and intravenous infusion.

Apr 15, 2025 · Takeda Pharmaceutical's ENTYVIO (vedolizumab) Overview Vedolizumab is a biologic medication approved for both intravenous (IV) and subcutaneous (SC) use, with …

Jul 31, 2024 · Find patient medical information for Entyvio (vedolizumab) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings